BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21861150)

  • 1. [Translational research in head and neck cancer. Biological characteristics and general aspects].
    Dietz A; Wichmann G
    HNO; 2011 Sep; 59(9):874-84. PubMed ID: 21861150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HPV-associated head and neck cancer. The basics of molecular and translational research].
    Wittekindt C; Wagner S; Klussmann JP
    HNO; 2011 Sep; 59(9):885-92. PubMed ID: 21769577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
    Wittekindt C; Wagner S; Mayer CS; Klußmann JP
    Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.
    Tehrany N; Kitz J; Rave-Fränk M; Lorenzen S; Li L; Küffer S; Hess CF; Burfeind P; Reichardt HM; Canis M; Beissbarth T; Wolff HA
    Strahlenther Onkol; 2015 Jul; 191(7):566-72. PubMed ID: 25575976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab.
    Heiduschka G; Grah A; Oberndorfer F; Seemann R; Kranz A; Kornek G; Wrba F; Thurnher D; Selzer E
    Strahlenther Onkol; 2014 Sep; 190(9):832-8. PubMed ID: 24715244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
    Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
    Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.
    Compton AM; Moore-Medlin T; Herman-Ferdinandez L; Clark C; Caldito GC; Wang XI; Thomas J; Abreo FW; Nathan CO
    Otolaryngol Head Neck Surg; 2011 Jul; 145(1):51-7. PubMed ID: 21493313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
    Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
    Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Promising approaches of translational research in head and neck cancer].
    Dietz A
    HNO; 2011 Sep; 59(9):857-8. PubMed ID: 21892801
    [No Abstract]   [Full Text] [Related]  

  • 11. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
    Bosch FX; Homann N; Conradt C; Dietz A; Erber R
    HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular characterization of penile cancer : Literature review of new prognostic markers and potential therapeutic targets].
    May M; Brookman-May SD; Ecke TH; Burger M
    Urologe A; 2018 Apr; 57(4):398-407. PubMed ID: 29470654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects.
    Klozar J; Tachezy R; Rotnáglová E; Košlabová E; Saláková M; Hamšíková E
    Wien Med Wochenschr; 2010 Jun; 160(11-12):305-309. PubMed ID: 20640929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma.
    Ryu HJ; Kim EK; Heo SJ; Cho BC; Kim HR; Yoon SO
    APMIS; 2017 Nov; 125(11):974-984. PubMed ID: 28975663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV-associated p16 INK4A expression and response to therapy and survival in selected head and neck cancers.
    Kanyilmaz G; Ekinci O; Muge A; Celik S; Ozturk F
    Asian Pac J Cancer Prev; 2015; 16(1):253-8. PubMed ID: 25640361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival.
    Wittekindt C; Gültekin E; Weissenborn SJ; Dienes HP; Pfister HJ; Klussmann JP
    Adv Otorhinolaryngol; 2005; 62():72-80. PubMed ID: 15608419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
    Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
    HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Examinations on the importance of the inactivation of the tumor suppressor gene p16, reactivation of the telomerase and mutation of p53 in the pathogenesis of head and neck tumors].
    Koscielny S
    Laryngorhinootologie; 2003 Mar; 82(3):197-8. PubMed ID: 12673521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.